Cite

OUTCOMES OF ALLOGENEIC SC TRANSPLANT IN HEMATOLOGICAL MALIGNANCY PATIENTS USING BUSULFAN 3 (9.6 MG/KG) BASED CONDITIONING REGIMEN

MLA

Majed Altareb, et al. “Outcomes of Allogeneic Sc Transplant in Hematological Malignancy Patients Using Busulfan 3 (9.6 Mg/Kg) Based Conditioning Regimen.” Hematology, Transfusion and Cell Therapy, vol. 43, no. S48-, Nov. 2021. EBSCOhost, https://doi.org/10.1016/j.htct.2021.10.1051.



APA

Majed Altareb, Yazeed Bajuaifer, & Walid Rasheed. (2021). Outcomes of Allogeneic Sc Transplant in Hematological Malignancy Patients Using Busulfan 3 (9.6 Mg/Kg) Based Conditioning Regimen. Hematology, Transfusion and Cell Therapy, 43(S48-). https://doi.org/10.1016/j.htct.2021.10.1051



Chicago

Majed Altareb, Yazeed Bajuaifer, and Walid Rasheed. 2021. “Outcomes of Allogeneic Sc Transplant in Hematological Malignancy Patients Using Busulfan 3 (9.6 Mg/Kg) Based Conditioning Regimen.” Hematology, Transfusion and Cell Therapy 43 (S48-). doi:10.1016/j.htct.2021.10.1051.